198 related articles for article (PubMed ID: 21134376)
1. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice.
Nijstad N; Gautier T; Briand F; Rader DJ; Tietge UJ
Gastroenterology; 2011 Mar; 140(3):1043-51. PubMed ID: 21134376
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
3. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice.
Kruit JK; Plösch T; Havinga R; Boverhof R; Groot PH; Groen AK; Kuipers F
Gastroenterology; 2005 Jan; 128(1):147-56. PubMed ID: 15633131
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-independent regulation of reverse cholesterol transport by liver X receptors.
Breevoort SR; Angdisen J; Schulman IG
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1650-60. PubMed ID: 24947527
[TBL] [Abstract][Full Text] [Related]
5. Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice.
Wiersma H; Gatti A; Nijstad N; Kuipers F; Tietge UJ
J Lipid Res; 2009 Aug; 50(8):1571-80. PubMed ID: 19252221
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8.
Yu L; York J; von Bergmann K; Lutjohann D; Cohen JC; Hobbs HH
J Biol Chem; 2003 May; 278(18):15565-70. PubMed ID: 12601003
[TBL] [Abstract][Full Text] [Related]
7. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.
Plōsch T; Kok T; Bloks VW; Smit MJ; Havinga R; Chimini G; Groen AK; Kuipers F
J Biol Chem; 2002 Sep; 277(37):33870-7. PubMed ID: 12105210
[TBL] [Abstract][Full Text] [Related]
8. Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice.
Freark de Boer J; Annema W; Schreurs M; van der Veen JN; van der Giet M; Nijstad N; Kuipers F; Tietge UJF
J Lipid Res; 2012 Mar; 53(3):348-357. PubMed ID: 22180634
[TBL] [Abstract][Full Text] [Related]
9. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol.
van der Veen JN; van Dijk TH; Vrins CL; van Meer H; Havinga R; Bijsterveld K; Tietge UJ; Groen AK; Kuipers F
J Biol Chem; 2009 Jul; 284(29):19211-9. PubMed ID: 19416968
[TBL] [Abstract][Full Text] [Related]
10. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice.
Xie P; Jia L; Ma Y; Ou J; Miao H; Wang N; Guo F; Yazdanyar A; Jiang XC; Yu L
Arterioscler Thromb Vasc Biol; 2013 May; 33(5):920-5. PubMed ID: 23471229
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8.
Calpe-Berdiel L; Rotllan N; Fiévet C; Roig R; Blanco-Vaca F; Escolà-Gil JC
J Lipid Res; 2008 Sep; 49(9):1904-11. PubMed ID: 18509196
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.
Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T
J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597
[TBL] [Abstract][Full Text] [Related]
14. Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.
Wiersma H; Nijstad N; de Boer JF; Out R; Hogewerf W; Van Berkel TJ; Kuipers F; Tietge UJ
Atherosclerosis; 2009 Sep; 206(1):141-7. PubMed ID: 19339012
[TBL] [Abstract][Full Text] [Related]
15. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.
Dikkers A; de Boer JF; Groen AK; Tietge UJ
Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893
[TBL] [Abstract][Full Text] [Related]
16. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
17. Abcg5/8 independent biliary cholesterol excretion in Atp8b1-deficient mice.
Groen A; Kunne C; Jongsma G; van den Oever K; Mok KS; Petruzzelli M; Vrins CL; Bull L; Paulusma CC; Oude Elferink RP
Gastroenterology; 2008 Jun; 134(7):2091-100. PubMed ID: 18466903
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
19. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.
Annema W; Dikkers A; Freark de Boer J; Gautier T; Rensen PCN; Rader DJ; Tietge UJF
J Lipid Res; 2012 May; 53(5):929-940. PubMed ID: 22383685
[TBL] [Abstract][Full Text] [Related]
20. rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment.
Maugeais C; Annema W; Blum D; Mary JL; Tietge UJ
Atherosclerosis; 2013 Jul; 229(1):94-101. PubMed ID: 23725986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
